NAVCO PHARMACEUTICALS INC (NAV.CA) Stock Income Statement
TSX-V:NAV • CA63942R1091
Current stock price
0.01 CAD
+0.01 (+100%)
Last:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 64.60K | 69.90K | 1.60M | 1.47M | |||
| Selling, General, and Administrative Expenses | 66.40K | 68.50K | 1.57M | 1.42M | |||
| Operating Income | -64.60K | -69.90K | -1.60M | -1.47M | |||
| Interest Income/Expense | -10.20K | -9.50K | -16.00K | -12.50K | |||
| Non Recurring Items | N/A | 0.00 | -105.90K | -667.10K | |||
| Income Before Taxes | -74.70K | -79.40K | -1.72M | -2.15M | |||
| Net Income | -74.70K | -79.40K | -1.72M | -2.15M | |||
| EBITDA | N/A | -68.50K | -1.53M | -1.42M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.00 | -0.00 | -0.03 | -0.07 | |||
| Statistics | |||||||
All data in CAD